Total Payments
$3,432
2024 Payments
$1,530
Companies
40
Transactions
198
Medicare Patients
1,415
Medicare Billing
$106,661
Payment Breakdown by Category
Food & Beverage$2,791 (81.3%)
Education$640.89 (18.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,791 | 190 | 81.3% |
| Education | $640.89 | 8 | 18.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $489.35 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $383.72 | 48 | $0 (2024) |
| GENZYME CORPORATION | $205.05 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $203.03 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $181.98 | 9 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $178.76 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $147.81 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $139.11 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $132.64 | 6 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $125.12 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,530 | 87 | Novartis Pharmaceuticals Corporation ($206.37) |
| 2023 | $1,319 | 81 | Janssen Biotech, Inc. ($217.34) |
| 2022 | $380.48 | 22 | Seagen Inc. ($77.99) |
| 2021 | $202.79 | 8 | Janssen Biotech, Inc. ($90.00) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | ZIIHERA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/27/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $13.26 | General |
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: VTE | ||||||
| 10/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug), ERLEADA, AKEEGA | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.18 | General |
| 10/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Hematology | ||||||
| 10/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $0.13 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 382 | 537 | $117,115 | $32,265 |
| 2022 | 8 | 433 | 575 | $127,857 | $35,757 |
| 2021 | 7 | 301 | 412 | $79,523 | $24,804 |
| 2020 | 6 | 299 | 382 | $57,499 | $13,835 |
Total Patients
1,415
Total Services
1,906
Medicare Billing
$106,661
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 127 | 200 | $38,062 | $11,589 | 30.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 65 | $16,510 | $5,020 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 50 | $16,850 | $4,063 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 76 | 116 | $14,576 | $4,030 | 27.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 35 | $17,815 | $3,809 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 48 | $8,448 | $2,464 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,267 | $821.19 | 25.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 11 | 12 | $1,587 | $469.92 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 131 | 161 | $29,785 | $9,894 | 33.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 62 | $31,558 | $7,665 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 89 | $22,606 | $5,897 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 88 | 121 | $14,641 | $4,697 | 32.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 42 | $14,154 | $3,567 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 64 | $11,264 | $2,856 | 25.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 17 | 23 | $2,783 | $913.63 | 32.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 12 | 13 | $1,066 | $266.68 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 113 | 176 | $32,560 | $11,318 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 72 | 89 | $10,769 | $3,580 | 33.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 37 | $9,398 | $2,502 | 26.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 16 | $8,144 | $2,096 | 25.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 23 | 23 | $7,751 | $2,041 | 26.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 42 | $7,392 | $1,975 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 23 | 29 | $3,509 | $1,292 | 36.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 135 | 181 | $21,901 | $4,876 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 86 | 105 | $19,425 | $4,620 | 23.8% |
About Azeb Lemma, NP
Azeb Lemma, NP is a Family healthcare provider based in Richmond, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1235591975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Azeb Lemma, NP has received a total of $3,432 in payments from pharmaceutical and medical device companies, with $1,530 received in 2024. These payments were reported across 198 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($2,791).
As a Medicare-enrolled provider, Lemma has provided services to 1,415 Medicare beneficiaries, totaling 1,906 services with total Medicare billing of $106,661. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Richmond, IN
- Active Since 03/22/2016
- Last Updated 05/17/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1235591975
Products in Payments
- IMBRUVICA (Drug) $227.08
- DARZALEX (Biological) $196.16
- KEYTRUDA (Biological) $181.98
- Enhertu (Drug) $171.37
- KISQALI (Drug) $143.69
- REBLOZYL (Biological) $103.89
- SARCLISA (Biological) $102.26
- MONOFERRIC (Drug) $95.97
- SOLIRIS (Biological) $90.95
- Trodelvy (Drug) $83.99
- Lenvima (Drug) $82.98
- OPDIVO (Biological) $77.06
- JEVTANA (Drug) $70.21
- FLOWTRIEVER CATHETER, S (Device) $67.08
- VENCLEXTA (Drug) $64.49
- PROMACTA (Drug) $51.89
- RYBREVANT (Drug) $50.12
- XTANDI (Drug) $38.67
- IBRANCE (Drug) $36.69
- ULTOMIRIS (Biological) $34.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Richmond
Ms. Kasiah Banks, N.p, N.P
Family — Payments: $28,489
Family $28,489
Hochong Smith Gilles, Fnp, FNP
Family — Payments: $24,160
Family $24,160
Kellie Rosanbalm, Aprn, APRN
Family — Payments: $12,194
Family $12,194
Amy Mullin
Family — Payments: $7,418
Family $7,418
Rachel Rodal, Np-C, NP-C
Family — Payments: $7,368
Family $7,368
April Morris, Fnp, FNP
Family — Payments: $7,336
Family $7,336